2023年(nian)全(quan)球制藥公司排(pai)行榜(bang)(bang)顯示,上(shang)(shang)榜(bang)(bang)50強藥企2022年(nian)度(du)銷售總額(e)為8941.42億(yi)美(mei)(mei)元,同(tong)比上(shang)(shang)年(nian)增(zeng)加了(le)382.46億(yi)美(mei)(mei)元。50強企業入(ru)圍門(men)檻(jian)為15.55億(yi)美(mei)(mei)元,同(tong)比上(shang)(shang)年(nian)降低了(le)14.04億(yi)美(mei)(mei)元。
從銷(xiao)售(shou)額(e)規(gui)模來看,2023年全球藥企(qi)(qi)50強名單中有4家(jia)企(qi)(qi)業(ye)銷(xiao)售(shou)額(e)突破500億(yi)美元(yuan),有18家(jia)企(qi)(qi)業(ye)銷(xiao)售(shou)額(e)在(zai)(zai)100-500億(yi)美元(yuan)之(zhi)間,有12家(jia)企(qi)(qi)業(ye)銷(xiao)售(shou)額(e)在(zai)(zai)50-100億(yi)美元(yuan)之(zhi)間,其余16家(jia)企(qi)(qi)業(ye)銷(xiao)售(shou)額(e)在(zai)(zai)50億(yi)美元(yuan)以下。
中(zhong)國方面(mian),2023年中(zhong)國共計有(you)四家(jia)藥(yao)企上榜,分別是中(zhong)國生物制藥(yao)(39名(ming))、上海醫藥(yao)(41名(ming))、江(jiang)蘇(su)恒瑞醫藥(yao)(43名(ming))、石(shi)藥(yao)集(ji)團(tuan)(48名(ming))。
排行 | 藥企 | 2022銷售額(億美元) | 2022研發費用(億美元) |
1 | Pfizer | 913.03 | 123.81 |
2 | AbbVie | 561.79 | 64.35 |
3 | Johnson & Johnson | 501.79 | 141.40 |
4 | Novartis | 500.79 | 90.88 |
5 | Merck & Co. | 496.27 | 118.42 |
6 | Roche | 479.09 | 147.81 |
7 | Bristol Myers Squibb | 454.17 | 100.16 |
8 | AstraZeneca | 429.98 | 95.00 |
9 | Sanofi | 403.53 | 71.56 |
10 | GSK | 382.54 | 63.37 |
11 | Takeda | 296.90 | 46.97 |
12 | Gilead Sciences | 266.15 | 49.68 |
13 | Eli Lilly | 254.63 | 71.91 |
14 | Novo Nordisk | 253.84 | 34.50 |
15 | Amgen | 225.36 | 43.41 |
16 | Boehringer Ingelheim | 194.73 | 53.86 |
17 | Bayer | 188.98 | 70.13 |
18 | Moderna | 184.35 | 29.93 |
19 | Viatris | 159.99 | 6.98 |
20 | CSL | 131.23 | 13.47 |
21 | Teva Pharmaceutical Industries | 120.71 | 8.38 |
22 | Astellas Pharma | 105.11 | 20.11 |
23 | Vertex Pharmaceuticals | 86.07 | 21.04 |
24 | Merck KGaA | 83.66 | 26.90 |
25 | Biogen | 79.88 | 22.31 |
26 | Otsuka Holdings | 73.57 | 21.46 |
27 | Daiichi Sankyo | 70.89 | 23.14 |
28 | Regeneron Pharmaceuticals | 68.94 | 38.31 |
29 | Bausch Health Companies | 65.69 | 5.29 |
30 | Organon | 60.38 | 5.22 |
31 | UCB | 56.63 | 17.82 |
32 | Perrigo Company | 54.36 | 1.25 |
33 | Sun Pharmaceutical Industries | 54.24 | 2.94 |
34 | Les Laboratoires Servier | 51.93 | N/A |
35 | Chugai Pharmaceutical | 11.20 | 11.20 |
36 | Abbott Laboratories | 48.85 | 26.06 |
37 | Grifols | 48.64 | 4.25 |
38 | Eisai | 45.96 | 12.28 |
39 | Sino Biopharmaceutical | 44.63 | 6.01 |
40 | Fresenius | 43.42 | 9.25 |
41 | Shanghai Pharmaceuticals Holding | 40.43 | 2.61 |
42 | Horizon Therapeutics | 40.22 | 4.77 |
43 | Jiangsu Hengrui Medicine | 40.10 | 8.93 |
44 | Jazz Pharmaceuticals | 36.34 | 6.10 |
45 | Menarini | 36.21 | N/A |
46 | Ipsen | 34.47 | 4.90 |
47 | BioNTech | 33.39 | 16.40 |
48 | CSPC Pharmaceutical Group | 33.34 | 5.11 |
49 | Incyte | 37.47 | 14.57 |
50 | Novavax | 15.55 | 12.35 |
PharmExec(美國制藥經理(li)人雜志)公布(bu)了“2022年(nian)全球制藥企業(ye)TOP50榜(bang)單”。榜(bang)...
中國(guo)董事局網與中國(guo)數(shu)據研究中心共同(tong)發(fa)布(bu)了“2022第(di)八屆(jie)中國(guo)最(zui)具影響力醫(yi)藥企(qi)業百強榜”。榜...
E藥(yao)經理人(ren)發布了(le)“2022中國醫藥(yao)創(chuang)新企業100強(qiang)榜(bang)單”。榜(bang)單以授權專(zhuan)利數量、專(zhuan)利施(shi)引(yin)總量...
米內網公布(bu)了“2021-2022年(nian)度中國連鎖藥店綜合實力百強、直營(ying)力百強兩(liang)份榜單”。榜單從...